People: Procter & Gamble Co (PG.N)
30 Sep 2016
Dr. Susan Desmond-Hellmann, M.D., is an Independent Director of the Procter & Gamble Company. Dr. Desmond-Hellmann is Chancellor and Arthur and Toni Rembe Rock Distinguished Professor, University of California, San Francisco (“UCSF”), where she has served since August 2009. From 2004 through 2009, Dr. Desmond-Hellmann served as president of product development at Genentech (a biotechnology company), where she was responsible for pre-clinical and clinical development, business development, and product portfolio management. Prior to joining Genentech in 1995, Dr. Desmond-Hellmann was associate director of clinical cancer research at Bristol-Myers Squibb Pharmaceutical Research Institute. She has been a Director of Facebook Inc. since March 2013. As Chancellor of UCSF, a member of the Howard Hughes Medical Institute board of trustees, Facebook director, and past president of product development at Genentech, Dr. Desmond-Hellmann has extensive leadership and technology experience. As a former member of the Federal Reserve Bank of San Francisco’s Economic Advisory Council, she also brings finance experience to the Board.
|Total Annual Compensation, USD||110,000|
|Restricted Stock Awards, USD||175,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||222|
|Fiscal Year Total, USD||285,222|